PMID,Title,Journal,Year
40598585,A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapies.,BMC medicine,2025
38541972,Risk of Diabetic Ketoacidosis Associated with Sodium Glucose Cotransporter-2 Inhibitors: A Network Meta-Analysis and Meta-Regression.,Journal of clinical medicine,2024
35316484,"Effects of Sodium/Glucose Cotransporter 2 (SGLT2) Inhibitors and Combined SGLT1/2 Inhibitors on Cardiovascular, Metabolic, Renal, and Safety Outcomes in Patients with Diabetes: A Network Meta-Analysis of 111 Randomized Controlled Trials.","American journal of cardiovascular drugs : drugs, devices, and other interventions",2022
34068655,"SGLT2 Inhibitors, What the Emergency Physician Needs to Know: A Narrative Review.",Journal of clinical medicine,2021
31686884,Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician's Guide.,"Diabetes, metabolic syndrome and obesity : targets and therapy",2019
31226886,Sodium-Glucose Cotransporters as Potential Therapeutic Targets in Patients With Type 1 Diabetes Mellitus: An Update on Phase 3 Clinical Trial Data.,The Annals of pharmacotherapy,2019
29042751,Spotlight on ertugliflozin and its potential in the treatment of type 2 diabetes: evidence to date.,"Drug design, development and therapy",2017
